NTI Days Away from Crucial Lab Results – Can its Cannabis Strain Treat Autism?
Catalyst Hunter
Archived
Dec 16, 2020
Neurotech International Ltd (ASX: NTI) is focused on the clinical applications of unique cannabis strains to treat neurological disorders such as autism and is set to commence human clinical trials early in 2021.
